When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
OBSV - ObsEva's linzagolix shows long-term effect in extension study
ObsEva SA
Long-term data from a Phase 2b clinical trial, EDELWEISS, evaluating ObsEva SA's (NASDAQ:OBSV) linzagolix for the treatment of endometriosis-associated pelvic pain showed a durable treatment benefit with the daily 75 mg and 200 mg doses.